Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000095

Chief Commercial Officer sold 104,124 shares at $25.90 ($2,696,322)

  • Chief Commercial Officer acquired 104,124 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Warren Eric Chief Commercial Officer 2026-06-26 Option exercise 10b5-1 +104,124 $13.24 $1,378,602 142,524 D
Warren Eric Chief Commercial Officer 2026-06-26 Sale 10b5-1 −104,124 $25.90 $2,696,322 38,400 D
Derivatives
Warren Eric Chief Commercial Officer 2026-06-26 Option exercise · Stock Option 10b5-1 −104,124 252,876 D
Open-market sales · 104,124 sh · avg $25.90 · $2,696,322
Loading xslF345X06/wk-form4_1782859276.xml…